Immune system processes

92 trials 29 recruiting

Filter these 92 trials by phase, country and sponsor.

Open in Search →

Phase I/II study of QEL-001 in A2-mismatch liver transplant patients Ended

2024-516193-30-01 Prevention of liver transplant rejection 7 2023-10-02
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term) Ended

2024-512580-31-00 Kidney Transplant Rejection 5 2023-07-21
PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patien… Ended

2022-501217-31-00 Hepatocellular carcinoma 10 2023-03-09
A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Year… Ended

2022-501067-40-00 Moderately to Severely Active Ulcerative Colitis 5 2021-11-30
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Patients with Systemic Lupus Erythematosus (ALLEGORY) Ended

2023-504774-38-00 Systemic Lupus Erythematosus (SLE) 5 2021-11-04
A study to learn if dapirolizumab pegol is safe and works long-term in people with systemic lupus erythematosus Ended

2023-506368-14-00 Systemic lupus erythematosus (SLE) 5 2021-09-07
Phase 2 Study of Axatilimab at 3 Different Doses in Patients with Chronic Graft Versus Host Disease. Ended

2024-512978-99-00 Chronic graft versus host disease (cGVHD) 4 2021-07-19
A study to evaluate the safety and tolerability of seladelpar in subjects with primary biliary cholangitis Ended

2024-511753-22-00 Primary Biliary Cholangitis 5 2021-05-26
Safety and Immunogenicity of Extended 2-dose Regimens of 9vHPV Vaccine Ended

2022-500256-37-00 Prevention of persistent anogenital HPV infection and d 5 2021-04-08
Methotrexate and Metformin in rheumatoid arthritis patients. Ended

2024-511033-35-00 rheumatoid arthritis (RA) 4 2020-12-03
Multicentre, open-label, randomised, two-arm, parallel-group, superiority study to assess bioavailability and practicability of Envarsus® co… Ended

2024-518033-28-00 Prophylaxis of transplant rejection in adult liver allo 6 2020-11-27
Benefit of a flash dose of corticosteroids in digestive surgical oncology: a randomized, double blind, placebo-controlled trial Ended

2024-513728-40-00 scheduled surgery for digestive cancer 5 2019-07-02
Adjuvant dendritic-cell immunotherapy plus temozolomide following surgery and chemoradiation in patients with newly diagnosed glioblastoma Ended

2024-515291-13-00 Glioblastoma grade IV 4 2016-04-01
A study to investigate whether treatment with a siplizumab-based regimen can induce allogeneic tolerance in liver transplant recipients. Halted

2023-508397-29-00 Prophylaxis against liver allograft rejection following 4 2022-06-29
Crossover study to investigate the safety and tolerability as well as the blood levels after three single doses of Tacrolimus, of which 2 ar… Ended

2025-525076-29-00 Phase I study in healthy male volunteers. Intended indi 3 2026-03-23
A treatment study in patients with WHIM Syndrome. Ended

2024-518461-10-00 WHIM Syndrome 5 2026-01-12
Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacok… Ended

2024-510582-42-02 Acute graft versus host disease (aGvHD) 4 2025-08-14
A phase 4, open-label study to evaluate the short-term innate immune response after administration of a COVID-19 mRNA vaccine (Comirnaty JN… Ended

2024-520304-26-00 COVID-19 6 2025-05-05
First-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of VTX-PID in healthy male volunteers Ended

2023-503892-83-00 Healthy volunteers with circulating Neutralising antibo 1 2024-12-27
PARADOX study Ended

2024-515278-28-00 ulcerative colitis 6 2024-11-15
A Phase 3, Placebo-controlled, Cross-over Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Attacks in Adolescents and Adu… Ended

2023-507268-37-00 Hereditary Angioedema 5 2024-07-29
A study evaluating the effects of GLPG3667 given as oral treatment in adults with active systemic lupus erythematosus. Ended

2023-503183-16-00 Systemic Lupus Erythematosus 4 2024-01-16
First-in-human interleukin-15-transpresenting Wilms’ tumor protein 1-targeting autologous dendritic cell vaccination in cancer patients Ended

2024-515296-35-00 Histologically or cytologically confirmed solid tumor o 7 2023-12-06
BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidne… Ended

2023-503336-41-00 Prophylaxis of Renal Allograft Rejection 4 2023-11-29